BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37405852)

  • 1. Transfusion of incompatible blood to a patient with alloanti-Sc1.
    George CE; Grimsley S; Cumber R; Thornton N; Davies H; Harris C; Massey E; Perera K
    Immunohematology; 2023 Jun; 39(2):70-71. PubMed ID: 37405852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monocyte monolayer assay, an
    Nance SJT
    Immunohematology; 2023 Jun; 39(2):61-69. PubMed ID: 37405851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion management of patients with alloanti-Gerbich antibodies: case report].
    Jovanović R; Bujandrić N; Lisulov S; Bogdanović S
    Srp Arh Celok Lek; 2011; 139(7-8):518-22. PubMed ID: 21980665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Easy identification of antibodies to high-prevalence Scianna antigens and detection of admixed alloantibodies using soluble recombinant Scianna protein.
    Seltsam A; Grueger D; Blasczyk R; Flegel WA
    Transfusion; 2009 Oct; 49(10):2090-6. PubMed ID: 19555420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of in vitro methods to predict the clinical significance of red blood cell alloantibodies.
    Nance SJ
    Immunohematology; 2018 Jan; 33(1):11-15. PubMed ID: 29608322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Red cell exchange to mitigate a delayed hemolytic transfusion reaction in a patient transfused with incompatible red blood cells.
    Irani MS; Karafin MS; Ernster L
    J Clin Apher; 2017 Feb; 32(1):59-61. PubMed ID: 27112240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Red blood cell transfusion in patients with anti-Yt
    Wong SM; Cawthorne T; Dennington PM; Hong FS
    Transfusion; 2021 Feb; 61(2):379-384. PubMed ID: 33410173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SCAR: The high-prevalence antigen 013.008 in the Scianna blood group system.
    Srivastava K; Albasri J; Alsuhaibani OM; Aljasem HA; Bueno MU; Antonacci T; Branch DR; Denomme GA; Flegel WA
    Transfusion; 2021 Jan; 61(1):246-254. PubMed ID: 33098316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An update on the Scianna blood group system.
    Brunker PAR; Flegel WA
    Immunohematology; 2019 Jun; 35(2):48-50. PubMed ID: 31246487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemolytic transfusion reaction caused by anti-Yt
    Raos M; Thornton N; Lukic M; Golubic Cepulic B
    Immunohematology; 2021 Mar; 37(1):13-17. PubMed ID: 33962487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay.
    Noumsi GT; Billingsley KL; Moulds JM
    Transfus Med; 2015 Apr; 25(2):92-100. PubMed ID: 25828731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The rare holley antibody associated with a severe hemolytic transfusion reaction: the importance of this antibody identification to find a compatible blood unit.
    Santos LD; Bub CB; Aravechia MG; Bastos EP; Kutner JM; Castilho L
    Einstein (Sao Paulo); 2020; 18():eRC4582. PubMed ID: 31531557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival Time of Cross-Match Incompatible Red Blood Cells in Adult Horses.
    Tomlinson JE; Taberner E; Boston RC; Owens SD; Nolen-Walston RD
    J Vet Intern Med; 2015; 29(6):1683-8. PubMed ID: 26478135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance of a subset of red blood cells to clearance by antibodies in a mouse model of incompatible transfusion.
    Liepkalns JS; Cadwell CM; Stowell SR; Hod EA; Spitalnik SL; Zimring JC
    Transfusion; 2013 Jun; 53(6):1319-27. PubMed ID: 23033973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of antibodies to antigens in the International Society of Blood Transfusion collections, 700 series of low-incidence antigens, and 901 series of high-incidence antigens.
    Lomas-Francis C
    Immunohematology; 2018 Jun; 34(2):39-45. PubMed ID: 29989417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red-cell alloimmunization profile in multi transfused patients: Findings and insights of a blood transfusion service.
    Pereira Bueno ML; Mitestainer MB; Da Silva JAR; Benites BD; Roversi FM
    Transfus Clin Biol; 2021 Aug; 28(3):258-263. PubMed ID: 33901640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation Analysis of Hemolytic Transfusion Reaction Induced by Low Titer Antibody].
    Luo YY; Ma CY; Fu LH; Yang X; Yu Y; Wang DQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):503-508. PubMed ID: 37096526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A suspected delayed hemolytic transfusion reaction mediated by anti-Joa.
    Jajosky RP; Lumm WC; Wise SC; Bollag RJ; Shikle JF
    Immunohematology; 2017 Jun; 33(2):73-75. PubMed ID: 28657766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management.
    Shirey RS; Boyd JS; Parwani AV; Tanz WS; Ness PM; King KE
    Transfusion; 2002 Nov; 42(11):1435-41. PubMed ID: 12421216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.